MOTS-C
Mitochondria-derived peptide studied for metabolic regulation and longevity.
What Is MOTS-C?
MOTS-C is a mitochondrial-derived peptide encoded by the mitochondrial genome. It is studied for its role in metabolic regulation, insulin sensitivity, and anti-aging mechanisms. MOTS-C activates AMPK signaling and promotes glucose metabolism through multiple pathways. Studies suggest it may play a role in mediating exercise-like metabolic benefits.
🔬 Mechanism of Action
MOTS-C is a 16-amino acid mitochondrial-derived peptide encoded within the 12S rRNA gene of the mitochondrial genome, making it one of the few peptides with a non-nuclear genomic origin. It exerts metabolic effects primarily through activation of AMPK (AMP-activated protein kinase), a central cellular energy sensor that promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. MOTS-C also interferes with the folate cycle and de novo purine synthesis to generate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), an endogenous AMPK activator, linking mitochondrial status to whole-body metabolic regulation.
Effectiveness Profile
Relative effectiveness scores derived from published preclinical literature across key endpoints.
Scores are qualitative aggregates from animal and in vitro studies and are not a medical claim. For educational purposes only.
Applications & Benefits
Key Study Findings
Identified as an exercise-mimicking peptide — plasma levels rise in response to physical exertion in human subjects
Shown to improve insulin sensitivity and glucose tolerance in diet-induced obese mouse models
AMPK activation by MOTS-C promotes skeletal muscle glucose uptake independent of insulin in preclinical studies
Circulating levels decline with age in both rodent and human studies, correlating with metabolic deterioration
Studies in aged mice demonstrate restoration of exercise capacity and metabolic flexibility following MOTS-C administration
Effect Timeline
Expected milestones based on published preclinical data.
Metabolic receptor engagement begins. Early appetite modulation and glucose sensitivity improvements detectable.
Progressive improvements in glucose and insulin dynamics. Meaningful weight and fat reduction begins.
Visceral fat reduction measurable. Lipid profiles and metabolic markers show improvement.
Continued metabolic improvement. Insulin sensitivity stabilizes at improved baseline; weight loss sustained.
Metabolic receptor engagement begins. Early appetite modulation and glucose sensitivity improvements detectable.
Progressive improvements in glucose and insulin dynamics. Meaningful weight and fat reduction begins.
Visceral fat reduction measurable. Lipid profiles and metabolic markers show improvement.
Continued metabolic improvement. Insulin sensitivity stabilizes at improved baseline; weight loss sustained.
Timelines are derived from preclinical animal studies. Individual results in laboratory settings may vary. For educational purposes only.
Dosing Protocol
Dosing information is derived from published animal studies and is provided for educational purposes only.
Reconstitution Calculator
Calculate exact BAC water volume and dose measurements for MOTS-C.
For laboratory use only. This calculator is a reference tool — verify all calculations before use. Always use sterile technique with bacteriostatic water and sterile syringes.
Synergistic Stack Combinations
Key Scientific Literature
A mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis
Key finding: MOTS-c activated AMPK signaling, reversed high-fat diet-induced obesity and insulin resistance in mice.
MOTS-c: a mitochondrial-encoded regulator of the nucleus-mitochondria communication
Key finding: Demonstrated MOTS-c travels to the nucleus during stress and regulates adaptive gene expression.
Citations reference published peer-reviewed studies. This is not a complete literature review. All studies were conducted in preclinical or controlled clinical settings. Content is for educational reference only.
Frequently Asked Questions
What is unique about MOTS-C's genomic origin?
MOTS-C is encoded within the mitochondrial genome — specifically the 12S rRNA gene — rather than the nuclear genome like most peptides. This makes it one of a small family of mitochondrial-derived peptides (MDPs) identified in recent years. Its mitochondrial origin means its expression is directly tied to mitochondrial metabolic status, and its circulating levels reflect mitochondrial health and energetic demands.
Why is MOTS-C described as an exercise mimetic?
Studies have shown that MOTS-C levels in plasma increase in response to acute aerobic exercise in human subjects. When administered exogenously in animal models, MOTS-C recapitulates metabolic adaptations associated with exercise including improved insulin sensitivity, AMPK activation, and enhanced mitochondrial fuel utilization. This has led to its classification among peptides that mimic certain molecular consequences of physical activity.
How does MOTS-C activate AMPK through the folate cycle?
MOTS-C has been shown to inhibit enzymes in the folate-dependent one-carbon metabolism pathway, leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) — a naturally occurring AMPK activator. AICAR binds the gamma subunit of AMPK and mimics the effect of elevated cellular AMP:ATP ratio, triggering AMPK-dependent metabolic reprogramming. This represents a mechanistic link between mitochondrial peptide signaling and cellular energy homeostasis.
Related Topics
MOTS-C
For educational use only · Verified vendor
Available In Bundles
Quality Assurance
Related Guides
Tirzepatide
Dual GIP/GLP-1 receptor agonist studied for weight management and metabolic health.
5-Amino-1MQ
NNMT inhibitor studied for fat loss, metabolism enhancement, and lean mass preservation.
AOD9604
GH fragment studied for targeted fat loss and cartilage repair — without systemic growth effects.